Cipla Allots 1,954 Equity Shares Under Employee Stock Option Schemes
Cipla Limited has allotted 1,954 fully paid-up equity shares under its Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021, as approved by the Operations and Administrative Committee on 18th March, 2026. The allotment increases the company's paid-up share capital to INR 1,61,55,65,262, comprising 80,77,82,631 equity shares of INR 2 face value each. The company has notified all relevant stock exchanges and depositories in compliance with SEBI regulations.
*this image is generated using AI for illustrative purposes only.
Cipla Limited has announced the allotment of 1,954 equity shares under its employee stock option schemes, marking another step in its employee compensation programs. The pharmaceutical company notified stock exchanges about this development on 18th March, 2026.
Share Allotment Details
The Operations and Administrative Committee of Cipla approved the allotment of 1,954 fully paid-up equity shares on 18th March, 2026. These shares were issued pursuant to the exercise of employee stock options and stock appreciation rights under two specific schemes:
| Parameter: | Details |
|---|---|
| Shares Allotted: | 1,954 equity shares |
| Face Value: | INR 2 each |
| Schemes: | Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 |
| Approval Date: | 18th March, 2026 |
| Approving Authority: | Operations and Administrative Committee |
Impact on Share Capital
Following this allotment, Cipla's capital structure has been updated to reflect the increased shareholding. The company's issued, subscribed and paid-up share capital now stands at INR 1,61,55,65,262.
| Capital Structure: | Current Position |
|---|---|
| Total Paid-up Capital: | INR 1,61,55,65,262 |
| Total Equity Shares: | 80,77,82,631 |
| Face Value per Share: | INR 2 |
Regulatory Compliance
The allotment was carried out in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Cipla has notified multiple stock exchanges about this development, including BSE Limited, National Stock Exchange of India Limited, and Societe de la Bourse de Luxembourg, ensuring full regulatory compliance across all listing jurisdictions.
The notification was signed by Company Secretary Rajendra Chopra and has been communicated to relevant depositories including Central Depository Services (India) Limited and National Securities Depository Limited for record-keeping purposes.
Historical Stock Returns for Cipla
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.17% | -2.07% | -7.71% | -17.71% | -17.79% | +57.80% |
How might Cipla's employee retention and talent acquisition be affected by the ongoing ESOP exercises in the competitive pharmaceutical industry?
What impact could the dilution from these equity allotments have on Cipla's earnings per share and dividend policy going forward?
Will Cipla expand or modify its employee stock option schemes in 2026 to align with evolving market compensation trends?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
